Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination task

Behavioural Pharmacology

Volumn 16, Issue 7, 2005, Pages 511-520

  Prus, A J ^a   Philibin, S D ^a   Pehrson, A L ^a   Porter, J H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antipsychotic; Chlorpromazine; Clozapine; Haloperidol; Olanzapine; Quetiapine; Rat; Risperidone; Schizophrenia; Sertindole; Three choice drug discrimination; Ziprasidone

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; DRUG VEHICLE; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CHOICE; DRUG DISCRIMINATION; DRUG SCREENING; DRUG SUBSTITUTION; MALE; NONHUMAN; RAT; TRAINING;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; GENERALIZATION, STIMULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE;

EID: 26244462875     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000172735.73876.06     Document Type: Article

References (36)

1. Arnt J, Skarsfeldt T (1998). Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63-101.
2. Bruhwyler J, Liegeois JF, Bergman J, Carey G, Goudie A, Taylor A, et al. (1997). JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: a review of its behavioural properties. Pharmacol Res 36:255-264.
3. Carey GJ, Bergman J (1997). Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs. Psychopharmacology 132:261-269.
4. Cools AR, Prinssen EP, Ellenbroek BA (1995). The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine. Psychopharmacology 119:428-439.
5. Fiorella D, Helsley S, Rabin RA, Winter JC (1997). Further investigations of the interactions of antipsychotics with the (-)2,5-dimethoxy-4- methylamphetamine (DOM) discriminative stimulus. Neuropharmacology 36:1463-1469.
6. Goas JA, Boston JE Jr (1978). Discriminative stimulus properties of clozapine and chlorpromazine. Pharmacol Biochem Behav 8:235-241.
7. Goldstein A (1964). Biostatistics: An Introductory Text. New York: Macmillan.
8. Goudie A, Taylor A (1998a). Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats. Psychopharmacology 135:392-400.
9. Goudie AJ, Taylor A (1998b). Olanzapine generalisation to the clozapine discriminative stimulus is determined by clozapine training dose. Br J Pharmacol 124S:54.
10. Goudie AJ, Smith JA, Cole JC (2004). Stimulus properties of the 'atypical' antipsychotic zotepine in rats: comparisons with clozapine and quetiapine. Pharmacol Biochem Behav 77:163-173.
11. Hoenicke EM, Vanecek SA, Woods JH (1992). The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. J Pharmacol Exp Ther 263:276-284.
12. Kane J, Honigfeld G, Singer J, Meltzer H (1988). Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796.
13. Kelley BM, Porter JH (1997). The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats. Pharmacol Biochem Behav 57:707-719.
14. Matz R, Rick W, Thompson H, Gershon S (1974). Clozapine - a potential antipsychotic agent without extrapyramidal manifestations. Curr Ther Res Clin Exp 16:687-695.
15. Meltzer HY, McGurk SR (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233-255.
16. Meltzer HY, Koenig JI, Nash JF, Gudelsky GA (1989). Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs. Acta Psychiatr Scand Suppl 352:24-29.
17. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, et al. (2003). Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60:82-91.
18. Millan MJ, Schreiber R, Dekeyne A, Rivet JM, Bervoets K, Mavridis M, et al. (1998). S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT) 1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol. J Pharmacol Exp Ther 286:1356-1373.
19. Millan MJ, Schreiber R, Monneyron S, Denorme B, Melon C, Queriaux S, et al. (1999). S-16924, a novel, potential antipsychotic with marked serotonin1a agonist properties. IV. A drug discrimination comparison with clozapine. J Pharmacol Exp Ther 289:427-436.
20. Moore NA (1999a). Olanzapine: preclinical pharmacology and recent findings. Br J Psychiatry Suppl 37:41-44.
21. Moore NA (1999b). Behavioural pharmacology of the new generation of antipsychotic agents. Br J Psychiatry Suppl 38:5-11.
22. Moore NA, Tye NC, Axton MS, Risius FC (1992). The behavioral pharmacology of olanzapine, a novel 'atypical' antipsychotic agent. J Pharmacol Exp Ther 262:545-551.
23. National Research Council (1996). Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press.
24. Nielsen EB (1988). Cholinergic mediation of the discriminative stimulus properties of clozapine. Psychopharmacology 94:115-118.
25. Philibin SD, Prus AJ, Pehrson AL, Porter JH (2005). Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice. Psychopharmacology 180:49-56.
26. Porter JH, Covington HE, Varvel SA, Vann RE, Warren TA (1998). Chlorpromazine as a discriminative stimulus in rats: generalization to typical and atypical antipsychotics. Drug Dev Res 48:38-44.
27. 2 dopamine receptors in the discriminative stimulus properties of the atypical antipsychotic clozapine in rats. Drug Dev Res 46:139-147.
28. Porter JH, McCallum SE, Varvel SA, Vann RE (2000a). The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats. Psychopharmacology (Berl) 148:224-233.
29. Porter JH, Varvel SA, Vann RE, Philibin SD, Wise LE (2000b). Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats. Psychopharmacology 149: 189-193.
30. Porter JH, Prus AJ, Varvel SA, Vann RE (2005). Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure. Psychopharmacology 178:67-77.
31. Prus AJ, Baker LE, Meltzer HY (2004). Discriminative stimulus properties of 1.25 mg/kg and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin and muscarinic receptor mechanisms. Pharmacol Biochem Behav 77:199-208.
32. Remington G, Kapur S (2000). Atypical antipsychotics: are some more atypical than others? Psychopharmacology 148:3-15.
33. Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, et al. (1996). Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124:57-73.
34. Smith JA, Goudie AJ (2002). Discriminative stimulus properties in rats of the novel antipsychotic quetiapine. Exp Clin Psychopharmacol 10: 376-384.
35. Stahl SM, Shayegan DK (2003). The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. J Clin Psychiatry 64 (suppl 19):6-12.
36. Wiley JL, Porter JH (1992). Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure. Pharmacol Biochem Behav 43:961-965.